|
Cohort outcomes for new cases confirmed by culture |
|||||||||||
| Total registered |
Total remaining in cohorts** n, % |
Excluded from cohorts* n, % |
Cured n, % |
Treatment completed n, % |
Successful treatment n,% rows e+f |
Failure n, % |
Default n, % |
Unsuccessful treatment n, % rows h+i |
Died n, % |
Lost and transferred out n, % |
|
|
|
|||||||||||
| a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
k |
l |
|
|
|||||||||||
| Civil |
569 |
467 (82.1) |
102(17.9) |
106 (22.7) |
263(56.3) |
369(79.0%) |
12(2.6) |
36 (7.7) |
48(10.3) |
28 (6.0) |
22 (4.7) |
| Smear+ |
207 |
161 (77.8) |
46 (22.2) |
106 (65.8) |
0 (0.0) |
106 (65.8%) |
11 (6.8) |
16 (9.9) |
27 (16.8) |
22 (13.7) |
6 (3.7) |
| Smear- |
362 |
306 (84.5) |
56 (15.5) |
0 (0.0) |
263 (85.9) |
263 (85.9%) |
1 (0.3) |
20 (6.5) |
21 (6.9) |
6 (2.0) |
16 (5.2) |
| Culture+ |
--- |
266 |
--- |
95 (35.7) |
103 (38.7) |
198 (74.4%) |
11 (4.1) |
23 (8.6) |
34 (12.8) |
25 (9.4) |
9 (3.4) |
| Culture- |
--- |
201 |
--- |
11 (5.5) |
160 (79.6) |
171(85.1%) |
1 (0.5) |
13 (6.5) |
14 (7.0) |
3 (1.5) |
13 (6.5) |
| Prison |
351 |
319 (90.9) |
32 (9.1) |
5 (1.6) |
218(68.3) |
223(69.9%) |
5 (1.6) |
3 (0.9) |
8 (2.5) |
0 (0.0) |
88(27.6) |
| Smear+ |
43 |
33 (76.7) |
10 (23.3) |
5 (15.2) |
11 (33.3) |
16 (48.5%) |
2 (6.1) |
0 (0.0) |
2 (6.1) |
0 (0.0) |
15 (45.5) |
| Smear- |
308 |
286 (92.9) |
22 (7.1) |
0 (0.0) |
207 (72.4) |
207 (72.4%) |
3 (1.0) |
3 (1.0) |
6 (2.1) |
0 (0.0) |
73 (25.5) |
| Culture+ |
--- |
74 |
--- |
4 (5.4) |
44 (59.5) |
48 (64.9%) |
3 (4.1) |
0 (0.0) |
3 (4.1) |
0 (0.0) |
23 (31.1) |
| Culture- |
--- |
245 |
--- |
1 (0.4) |
174 (71.0) |
175 (71.4%) |
2 (0.8) |
3 (1.2) |
5 (2.0) |
0 (0.0) |
65 (26.5) |
| Total |
920 |
786 (85.4) |
134(14.6) |
111 (14.1) |
481(61.2) |
592(75.3%) |
17(2.2) |
40 (5.1) |
57 (7.3) |
28 (3.6) |
110(14.0) |
| Smear+ |
250 |
194 (77.6) |
56 (22.4) |
111 (57.2) |
11 (5.7) |
122 (62.9%) |
13(6.7) |
16 (8.2) |
29 (14.9) |
22 (11.3) |
21(10.8) |
| Smear- |
670 |
592 (88.4) |
78 (11.6) |
0 (0.0) |
470 (79.4) |
470 (79.4%) |
4 (0.7) |
23 (3.9) |
27 (4.6) |
6 (1.0) |
89(15.0) |
| Culture+ |
--- |
340 |
--- |
99 (29.1) |
147 (43.2) |
246 (72.4%) |
14 (4.1) |
23 (6.8) |
37(10.9) |
25 (7.4) |
32 (9.4) |
| Culture- |
--- |
446 |
--- |
12 (2.7) |
334 (74.9) |
346 (77.6%) |
3 (0.7) |
16 (3.6) |
19 (4.3) |
3 (0.7) |
78 (17.5) |
|
*a proportion of patients were excluded from cohort (transferred to a different regimen due to MDR TB, extensive radiological abnormalities, drug adverse reactions, severe accompanying pathology) ** N of patients remained in the cohort (column "total") is taken as a denominator | |||||||||||
Balabanova et al. Respiratory Research 2006 7:44 doi:10.1186/1465-9921-7-44 |
|||||||||||